[Gender differences in suicidal behavior].
Gender-specific differences in suicidal behaviour have been analysed in a number of recent studies. According to these, several socioeconomic, demographic, psychiatric, familial, help-seeking differences can be identified in protective and risk factors between males and females. Gender is one of the most replicated predictors for suicide. In the framework of the WHO/EURO Multicentre Study on Suicidal Behaviour, more than fifty thousand suicide attempts have been registered so far. Until now data on more than 1200 monitored suicidal events have been collected in Pecs centre. In most countries male suicid rates are higher. In contrast to suicides, rates of suicide attempts are usually higher in females. Concerning the differences in methods, it is a recognised fact that males use violent methods of both suicide and attempted suicide more often than females. The summarised clinical impression suggests that compliance of male patients is poorer than that of females. According to our data, a typical male attempter is characterised as follows: unemployed, never married, lives alone. He tends to use violent methods; if he takes drugs, it is mostly meprobamate or carbamazepine. A lot of male attempters have alcohol problems or dependence. As for the females, we found high odds ratios in the following cases: divorced or widowed, economically inactive, depressive state in the anamnesis. Female attempters are mainly repeaters using the method of self-poisoning, mostly with benzodiazepines. As suicide is a multicausal phenomenon, its therapy and prevention should also be complex and gender differences should be taken into account in building up our helping strategies.
Vörös
Viktor
V
Pécsi Tudományegyetem, Altalános Orvostudományi Kar, Pszichiátriai Klinika.
Osváth
Péter
P
Fekete
Sándor
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001569:Benzodiazepines / Q000008:administration & dosage; D002220:Carbamazepine / Q000008:administration & dosage; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D006993:Hypnotics and Sedatives / Q000008:administration & dosage; D008297:Male; D008620:Meprobamate / Q000008:administration & dosage; D008875:Middle Aged; D009125:Muscle Relaxants, Central / Q000008:administration & dosage; D012307:Risk Factors; D012651:Self Medication; D017678:Sex Distribution; D012737:Sex Factors; D013405:Suicide / Q000523:psychology / Q000706:statistics & numerical data*; D014944:World Health Organization; D000092864:Suicide Prevention
D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D001569:Benzodiazepines; D002220:Carbamazepine; D008620:Meprobamate